GLP-1s and the ‘Wild West’ of Wellness

0:00-1:13:57

Here’s a shocking number: One out of eight American adults is taking a GLP-1, like Ozempic or Zepbound, according to a KFF poll. GLP-1s are the biggest pharmaceutical story since antidepressants. But there’s still so much we don’t know. “We’re only at the beginning of what’s been called this Ozempic era,” the journalist Julia Belluz told me. “I think we’re really just at the beginning of discovering the benefits and the harms of these drugs.” These discoveries begin in the research but are also expanding into how we think about our puni...

Publisher

The Ezra Klein Show

Link

www.nytimes.com/2026/05/08/opinion/ezra-klein-podcast-julia-belluz.html

Published

May 8, 2026

Duration

1h 14m

Format

Podcast

Category

Lifestyle · Culture

Source

RSS feed

Host

New York Times Opinion

TE

The Ezra Klein Show

@ezraklein

#wildwest #wellness

The Nile